Detalhe da pesquisa
1.
Nonclinical safety evaluation of sunitinib: a potent inhibitor of VEGF, PDGF, KIT, FLT3, and RET receptors.
Toxicol Pathol
; 36(7): 905-16, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18981453
2.
PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer.
Mol Cancer Ther
; 6(12 Pt 1): 3158-68, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18089710